Corteva (NYSE:CTVA) Releases FY 2025 Earnings Guidance

Corteva (NYSE:CTVA) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 2.700-2.950 for the period, compared to the consensus earnings per share estimate of 3.190. The company issued revenue guidance of $17.2 billion-$17.6 billion, compared to the consensus revenue estimate of $17.3 billion.

Corteva Trading Down 3.2 %

CTVA stock traded down $2.08 during midday trading on Wednesday, hitting $63.62. 8,909,398 shares of the company’s stock were exchanged, compared to its average volume of 3,400,137. Corteva has a 1-year low of $50.01 and a 1-year high of $66.24. The business has a 50-day simple moving average of $60.20 and a two-hundred day simple moving average of $58.07. The stock has a market capitalization of $43.72 billion, a PE ratio of 64.26, a P/E/G ratio of 1.71 and a beta of 0.78. The company has a current ratio of 1.50, a quick ratio of 0.96 and a debt-to-equity ratio of 0.08.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 4.18% and a return on equity of 6.63%. On average, sell-side analysts predict that Corteva will post 2.58 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date of this dividend is Monday, March 3rd. Corteva’s payout ratio is 68.69%.

Corteva announced that its Board of Directors has authorized a share buyback plan on Tuesday, November 19th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the company to purchase up to 7.5% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Barclays lifted their target price on Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 21st. Bank of America increased their target price on shares of Corteva from $67.00 to $69.00 and gave the stock a “buy” rating in a report on Wednesday, November 20th. Wells Fargo & Company boosted their price target on shares of Corteva from $67.00 to $73.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 28th. Royal Bank of Canada increased their price objective on Corteva from $68.00 to $73.00 and gave the company an “outperform” rating in a research note on Thursday, December 19th. Finally, Citigroup boosted their target price on Corteva from $69.00 to $74.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $67.06.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.